Brightspring Health Services, Inc. (BTSG) Stock Price & Analysis

Brightspring Health Services, Inc. (BTSG) rose 3.01% to USD 61 as of June 10, 2026 at 00:49 UTC, according to Nexqual real-time market data.

BTSG last closed at USD 59.22; the session ranged USD 59.03–61.38 on volume of 5,098,042 shares. Market capitalization is $11.97B, with a 52-week range of USD 19.01–62.11 (NMS). Source: Nexqual, June 10, 2026 at 00:49 UTC.

Key Statistics (as of June 10, 2026 at 00:49 UTC)

Technical Analysis (BTSG)

Nexqual's technical model rates BTSG "BUY" based on 5 bullish and 1 bearish signals across 124 daily candles, as of June 10, 2026 at 00:49 UTC.

Analyst Ratings (BTSG)

Wall Street analysts rate BTSG "Strong Buy" based on 15 analysts, with a mean price target of USD 62 (range USD 49–71), per Nexqual as of June 10, 2026 at 00:49 UTC.

Earnings (BTSG)

Recent Earnings History

Source: Nexqual, June 10, 2026 at 00:49 UTC.

Financials & Fundamentals (BTSG)

Source: Nexqual, June 10, 2026 at 00:49 UTC.

Financial Health Score (BTSG)

Nexqual rates Brightspring Health Services, Inc.'s overall financial health "Mixed" across five dimensions, as of June 10, 2026 at 00:49 UTC.

Ownership (BTSG)

Source: Nexqual, June 10, 2026 at 00:49 UTC.

Leadership (BTSG)

Brightspring Health Services, Inc. is led by Jon B. Rousseau (age 51), Chairman, President & CEO, per Nexqual as of June 10, 2026 at 00:49 UTC.

Major Backers & Investors (BTSG)

Notable institutional backers of Brightspring Health Services, Inc. include Kohlberg Kravis Roberts & Co. L.P., FMR, LLC, T. Rowe Price, according to Nexqual as of June 10, 2026 at 00:49 UTC.

Active Investors

Index Funds (Passive)

Source: Nexqual, June 10, 2026 at 00:49 UTC.

From Brightspring Health Services, Inc.'s Latest SEC 10-K Filing (filed 2026-02-27)

Key Strengths & Strategy (as disclosed to the SEC)

• In 2020, we also completed the implementation of a financial systems transformation, including the implementation of Oracle Fusion and a new budgeting and forecasting system.
• We believe that we are positioned to identify potential medical problems and avoid adverse events due to our highly proximate position to patients. • Market-leading scale with a focus on operational excellence and coordinated front-line care – We manage one of the nation's largest independent platforms of both pharmacy and provider services offered on a daily basis in home and community settings – to address the multiple needs of medically complex Senior and Specialty patients.
• Over $40 billion in annual U.S. health care spending is attributed to hospital readmissions, and home health care can reduce 365-day post-discharge costs by more than $6,000 per patient, each per the American Journal of Medicine.
• Scale from our pharmacy and provider businesses allow us to effectively deliver and coordinate integrated solutions to and across patient types and care settings, which we believe will be more important in the ongoing development of value-based care solutions.

Partnerships

• On January 17, 2025, we entered into a purchase agreement with National Mentor Holding, Inc. to divest the Company's community living services, home and community based waiver programs, and intermediate care facilities (the "Community Living business"), for $835 million, subject to typical adjustments for working capital and other customary items.

Source: SEC EDGAR 10-K, official filing. Curated by Nexqual.

Peers & Related Stocks

Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: June 10, 2026 at 00:49 UTC. This page is informational and not investment advice.